MedTrace Logo

A Study of the Rate of Progression of Glaucoma During a Follow-up Period of Two Years

NCT01629407 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 315

Last updated 2013-06-20

No results posted yet for this study

Summary

This is an epidemiological, non-interventional, prospective study to collect data on glaucoma progression in a routine setting. Patients may receive treatment at the discretion of their physician per local standard of care.

Conditions

  • Glaucoma, Open-Angle

Interventions

OTHER

Standard of Care

Patients with glaucoma treated with standard of care at the discretion of the physician. There is no specific treatment required for this study.

Sponsors & Collaborators

  • Allergan

    lead INDUSTRY

Principal Investigators

  • Medical Director · Allergan

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-06-30
Primary Completion
2013-05-31
Completion
2013-05-31

Countries

  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01629407 on ClinicalTrials.gov